Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2025-09-05 00:00:00 ET · period of report 2025-09-03 · accession 0001415889-25-023786 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-09-05 | 2025-09-03+ | TVTX | Cline Christopher R. | CFO | S - Sale | $18.51 | -573 | 92.1K | -0.6% | -$10.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-03 | S | D | 454 | $18.20 | 92,202 | D | — | — | |
| 2 | Common | Common Stock | 2025-09-04 | S | D | 119 | $19.71 | 92,083 | D | — | — |